In vitro skin irritation testing has emerged as a critical component in the safety evaluation of chemicals and medical devices, aiming to replace traditional animal-based assays. Central to this ...

The role of in vitro testing in modern cosmetic development Ensuring the safety and performance of cosmetic products is a critical requirement for manufacturers operating in today’s regulated and ...

The global in vitro toxicity testing market is expected to expand at a compound annual growth rate of around 10% during the forecast period, reflecting the increasing need for safer, faster, and more ...

Reproducible in-vitro canine skin has been grown in a laboratory setting for the first time by researchers at the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB. The research ...

Chicago, Feb. 03, 2026 (GLOBE NEWSWIRE) -- The global in-vitro toxicology testing market was valued at 26.00 billion in 2024 and is expected to reach US$ 57.55 billion by 2033, growing at a CAGR of ...

In Vitro–In Vivo Extrapolation (IVIVE) is a method that allows researchers to predict the rate at which substances are metabolized within the human liver and are then eliminated from the body. IVIVE ...

Although several countries—and even some U.S. states—are beginning to create laws that ban or limit the practice of animal testing for cosmetics, the sad reality is that some companies continue to ...

Non-Alcoholic Fatty Liver Disease (NAFLD) Affects 30-40% of U.S. Adults, Driving Significant Market Need for BioHarvest's Future Olive Cell Product Targeting Liver Health Vancouver, British Columbia ...

Virtue may be its own reward, but for Virtue Diagnostics, at least, a fresh infusion of venture capital is a close second. Only about two years after its founding, the in vitro testing company has ...

FOR BIOTECH, DEB, IT REALLY IS. IN THE PAST LEGISLATIVE SESSION, MARYLAND’S GENERAL ASSEMBLY PASSED A BILL PROVIDING GRANTS TO MARYLAND SCIENTISTS WHO DEVELOP NON ANIMAL BASED RESEARCH METHODS. IT WAS ...

A federal district court has struck a blow for medical innovation and patient empowerment by overruling the Food and Drug Administration's (FDA) misbegotten effort to regulate laboratory-developed ...